Comparison of Clinical, Laboratory and Radiological Characteristics Between COVID-19 and Adenovirus Pneumonia: A Retrospective Study
Juan Jiang,Rongjun Wan,Pinhua Pan,Chengping Hu,Rihua Zhou,Yiping Yin,Ting Zhou,Hua Huang,Yuanyuan Li
DOI: https://doi.org/10.2147/IDR.S264132
2020-10-02
Infection and Drug Resistance
Abstract:Juan Jiang, 1 Rongjun Wan, 1 Pinhua Pan, 1 Chengping Hu, 1 Rihua Zhou, 2 Yiping Yin, 2 Ting Zhou, 2 Hua Huang, 2 Yuanyuan Li 1 1 Department of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, Hunan Province, People's Republic of China; 2 Medical Center of Tuberculosis, The Second People's Hospital of Chenzhou, Chenzhou, Hunan Province, People's Republic of China Correspondence: Yuanyuan Li Department of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha 410008, People's Republic of China Tel +86 13975806790 Email leeround@csu.edu.cn Hua Huang Medical Center of Tuberculosis, The Second People's Hospital of Chenzhou, Chenzhou 423000, People's Republic of China Tel +86 18673561888 Email huahua1888@foxmail.com Background: The pandemic of coronavirus disease 2019 (COVID-19) has become a global public health problem. It is important for clinical physicians to differentiate COVID-19 from other respiratory infectious diseases caused by viruses, such as human adenovirus. Subjects and Methods: This was a retrospective observational study. We analyzed and compared the clinical manifestations, laboratory findings and radiological features of two independent cohorts of patients diagnosed with either COVID-19 (n=36) or adenovirus pneumonia (n=18). Results: COVID-19 did not show a preference in males or females, whereas 94.4% of patients with adenovirus pneumonia were males. Fever and cough were common in both COVID-19 and adenovirus pneumonia. But the median maximal body temperature of the adenovirus pneumonia cohort was significantly higher than in COVID-19 ( P < 0.001). Furthermore, 77.8% of patients with adenovirus pneumonia had a productive cough versus only 13.9% of COVID-19 patients ( P < 0.001). Compared with adenovirus pneumonia, constitutional symptoms were less common in COVID-19, including headache (16.7% vs 38.9%, P =0.072), sore throat (8.3% vs 27.8%, P =0.058), myalgia (8.3% vs 61.1%, P < 0.001) and diarrhea (8.3% vs 44.4%, P =0.002). Furthermore, patients with COVID-19 were less likely to develop respiratory failure (8.3% vs 83.3%, P < 0.001) and showed less prominent laboratory abnormalities, including lymphocytopenia (61.1% vs 88.9%, P =0.035), thrombocytopenia (2.8% vs 61.1%, P < 0.001), elevated procalcitonin (2.8% vs 77.8%, P < 0.001) and elevated C-reactive protein (36.1% vs 100%, P < 0.001). Besides, a higher percentage of patients with adenovirus pneumonia showed elevated transaminase, myocardial enzymes, creatinine and D-dimer compared with COVID-19 patients. On chest CT, the COVID-19 cohort was characterized by peripherally distributed ground-glass opacity and patchy shadowing, while the adenovirus pneumonia cohort frequently presented with consolidation and pleural effusion. Conclusion: There were many differences between patients diagnosed with COVID-19 and those with adenovirus pneumonia in their clinical, laboratory and radiological characteristics. Compared with adenovirus pneumonia, COVID-19 patients tended to show a lower severity of illness. Keywords: coronavirus disease 2019, severe acute respiratory syndrome coronavirus 2, human adenovirus, adenovirus pneumonia, differential diagnosis
pharmacology & pharmacy,infectious diseases